http://www.rxboomer.com/articles/Drug-Companies_Summary.html There are occasions in life when you need medication to treat or prevent some physiological and psychological diseases. If that is the case, it is your responsibility to keep well informed about the proper usage and recommended dosage of the medicine. Likewise, it is crucial and even more important to know what pharmaceutical companies are in charge of producing that medication. Thinking about this, we have at your disposal a series of articles about some of these companies. en-us http://www.rxboomer.com/articles/Drug-Companies_17048.html Tue, 30 May 2006 06:36:18 CST A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.

Warner Chilcott PLC is a specialty pharmaceutical company focused on two core therapeutic areas of women’s healthcare and dermatology. The acquisition of their U.S. subsidiary in October 2000 afforded them access to the U.S. pharmaceuticals market where they have achieved impressive growth. Since then, they have invested further in building their U.S. pharmaceuticals business. Their strategy for growth remains constant and comprises three elements which is the continued growth of their pharmaceutical business, the internal development of new proprietary products, the acquisition and licensing of products that complement and strengthen their existing product range.
 
At Warner Chilcott, their sales and marketing activities are an important part of their continued success. They continue to gain market share in their core therapeutic areas of women's healthcare and dermatology. Their sales strategy is focused on employing precision marketing techniques to market and promote their key branded products to high volume prescribing physicians. They analyze prescription data and develop strategies and tactics to maximize growth in their sales and market share.
 
Warner Chilcott is proud of the leadership provided by its senior management team, and is confident that this team will continue to have a sharp focus on growing the Company. Warner Chilcott's leadership has guided them through the development of new products, strategic acquisitions and the successful promotion of their products, and is committed to their fast growing pharmaceutical business. 

Warner Chilcott maintains a strong and ongoing commitment to openness with their shareholders regarding their business and forward strategies. They extend their appreciation to the continued confidence of their investors, and they reiterate their commitment to maintain their sharp focus on maximizing growth and shareholder value. http://www.rxboomer.com/articles/Drug-Companies_17046.html Tue, 30 May 2006 06:33:42 CST They are former staff members of University of California with over 600 publications Concerning Soil Science, Plant Nutrition, Plant Physiology and Heavy Metal Toxicity. They extend their university training and experience to your particular needs. They offer the State of the Art recommendations.
 
Wallace Laboratories has many years of experience in assisting farmers, professional landscaping companies and home owners produce better gardens and improving landscape by analyzing soils, plant tissues and water.
 
Wallace Laboratories analyze for all nutrients and many toxic metals. Water analysis is also recommended to help with better growth. Plant Tissues are analyzed to optimize the growing conditions and to fine tune your landscaping site.
 
To the left you'll find their different services they offer here at Wallace Labortories.The gap between average crop yield and what better growers are getting can be filled. This goal is number one. Even the gap between yields of better growers and record yields can become more narrow. This is goal number two. These goals can be largely met with creation of better soil and with more attention to management details. The use of the concept of the Law of the Maximum will be essential. The goals can be met without new breakthroughs in plant biology. Such advancements, however, will be welcome.  The principles outlined can also be used for very small scale agriculture as well as for large-scale agriculture. Slight modifications may be necessary for some.
 
This unique volume features scientific, technical and practical information on mineral, organic and synthetic conditioners and their beneficial effects of the soil physical properties that promote optimal plant growth maximize soil fertility and enhance other inputs. http://www.rxboomer.com/articles/Drug-Companies_17044.html Tue, 30 May 2006 06:30:56 CST Since 1919, Upsher-Smith Laboratories has grown into one of the world’s top pharmaceutical companies. This growth is due to their company’s quest for Excellence through Innovation. With state of the art facilities located in Minneapolis, Minnesota and Denver, Colorado, they develop, manufacture and market an array of products that advance human health.
 
Their proven legacy of excellence and ongoing focus on innovation establish a foundation for their continued success.

Upsher-Smith's branded generics answer the healthcare industry's need for reliable, affordable pharmaceutical products. Upsher-Smith is a leader in this growing segment of the pharmaceutical market.

They are proud of the success Upsher-Smith has achieved. As entrepreneurs, they have built a unique product development, manufacturing and marketing model to advance their key strategic partnerships. Privately owned and independent, Upsher-Smith is able to act quickly and efficiently.

Their employees share a keen commitment to excellence; one that has fueled their legacy of innovation and success. In their strategic alliances, the passion of their people crosses corporate borders to help meet shared goals.

They have cultivated and advanced customer relationships to build a wide distribution network that serves pharmacies large and small. From the independent pharmacist to nationwide chains, their trade customers have come to rely upon Upsher-Smith to supply them rapidly with effective, economic pharmaceuticals in quantities to meet any level of demand. This high-volume output has kept their unit sales and revenues equally high.

Their unique branding approach offers clinicians a vital therapeutic option of economically priced medications delivered with brand quality service and support. And, as a pharmaceutical company founded and run by pharmacists, they truly understand the challenges faced by pharmacies across the country as they ultimately help patients receive brand quality at economic prices.

They have enjoyed great success in developing, manufacturing and marketing products in the areas of cardiology and dermatology. Recent licensing agreements have expanded their offerings into the area of women’s health as well. Their corporate development staff is seeking the right opportunities not only to strengthen and expand their partnerships, but also to maximize the life-cycle management and profitability of mature products.

Much of their success stems from the fruitful partnerships. Upsher-Smith has built over the years with other pharmaceutical manufacturers and research companies. They seek to build upon that success by developing licensing, joint ventures, profit sharing, co-development, co-marketing, and other arrangements. As an independent company, they can act swiftly to create the right partnerships for innovation and excellence. http://www.rxboomer.com/articles/Drug-Companies_17041.html Tue, 30 May 2006 06:27:06 CST United Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. In these segments, United Therapeutics is actively developing four technology platforms: Prostacyclin Analogs, Immunotherapeutic Monoclonal Antibodies, Glycobiology, and Telemedicine. United Therapeutics Corporation is incorporated in Delaware and is listed on the NASDAQ stock market.

At United Therapeutics, they find tremendous inspiration for their work and view their products as being new beginnings for patients and doctors, with quality of life as their utmost therapeutic goal. The theme of United Therapeutics is Medicines for Life because all of their therapeutics addresses life-threatening illnesses.

Much of United Therapeutics' resources are focused on cardiovascular health, including developing analogs of the endogenous hormone prostacyclin  for the treatment of pulmonary arterial hypertension and critical limb ischemia and a variety of telemedicine services for patients with an array of possible cardiac arrhythmias.

United Therapeutics' second principal focus is oncology and the company is undertaking the largest ever pivotal trial of a potential medicine for preventing the recurrence of ovarian cancer. This medicine is part of a family of similar immunotherapeutic monoclonal antibody therapies licensed to United Therapeutics which are designed to combat prostate, breast, lung, pancreatic, colorectal and multiple myeloma cancers.

United Therapeutics's third focus is in the field of infectious disease, where the company is targeting hepatitis C and other diseases with unique glycobiology compounds. While this work is at an early stage, it holds immense promise. The diseases being targeted afflict over a billion people worldwide, and the compounds are part of an entire new class of pharmacological agents.

They strive for balance within and across their therapeutic areas. Their cardiovascular drug development strategy is balanced with a commercialized use pulmonary arterial hypertension, as well as novel uses and new routes of administration. And their overall company strategy is balanced among mature programs cardiovascular, pivotal development oncology, and early-stage pipeline activities infectious disease.

The company's mission is carried out using corporate partners for product sales and academic centers for research whenever feasible, complemented by in-house commercialization professionals and their commitment to providing doctors and patients with accurate information and ongoing research related to their products. This strategy streamlines company overhead and enables company employees to concentrate on clinical trials, regulatory approvals and business development. United Therapeutics generally retains all rights to the products it develops. http://www.rxboomer.com/articles/Drug-Companies_17039.html Tue, 30 May 2006 06:25:02 CST Unimed Pharmaceuticals, Inc is the company that is now a wholly owned subsidiary of Solvay Pharmaceuticals.  This firm focuses on developing and marketing drugs with multiple indications in the specialized markets of men's health urology and endocrinology, HIV and other infectious diseases.
 
They are dedicated to optimal patient health management. The firm’s commitment is to contribute to an increasing portion of corporate growth, revenues and profit. Within their defined therapeutic areas, the Company intends to be among the leading global pharmaceuticals companies in providing health management.
 
The Company will strengthen their position through global market presence and by marketing a product portfolio of unique and complete treatments. They will build their product portfolio through discovery, development, licensing and acquisition of pharmaceuticals.
 
The firm has innovative drug development, including first to market and category leading products among its core therapeutic areas. Research scientists join the organization because of its rich history and track record of bold innovations.  While some scientists spend their careers in search of the next blockbuster drug therapy, their innovators are given the time and dedicated resources it takes to win smaller scale victories focused on their niche therapeutic areas of cardiology, gastroenterology, mental health, women’s health and specialized markets.  Their efforts target often neglected and under treated patient. 
 
They believe that collaboration with others is a major factor in their strength and innovation.  By working together with government, patient groups and professional associations, they are better able to understand and meet the needs of their customers and physicians.  By working together with other pharmaceutical companies, they are able to accelerate the rate at which they can make products available to the market. 

Their success will be based on attracting, developing and retaining talented and motivated employees with the ability and the commitment to excel. http://www.rxboomer.com/articles/Drug-Companies_17038.html Tue, 30 May 2006 06:23:30 CST A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.

UCB is a leading global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology. UCB focuses on securing a leading position in severe disease categories.

UCB's medicines are making a real difference to the lives of people all over the world. Some of their products are among the leaders in their field. Keppra levetiracetam is indicated as add-on antiepilepsy treatment for adults and children from 4 years of age with partial onset seizures. Nootropil piracetam is a cerebral function regulator, used to treat adults and the elderly.

Xyzal levocetirizine is an antihistamine treatment for symptoms associated with allergic conditions such as seasonal allergic rhinitis including ocular symptoms, perennial allergic rhinitis, chronic idiopathic urticaria. Zyrtec cetirizine is an antihistamine treatment for the symptoms of perennial allergic rhinitis, seasonal allergic rhinitis and chronic idiopathic urticaria. In the US Zyrtec is licensed and co-promoted with Pfizer Inc.

Tussionex hydrocodone polistirex and chlorpheniramine polistirex is used for relief of cough and upper respiratory symptoms associated with allergy or cold. Metadate Equasym methylphenidate HCl is used in the treatment of Attention Deficit Hyperactivity Disorder. For many years, UCB has responded to changing needs for better healthcare. Their medicines aim to bring longer lives and healthier living to people all over the world.

They are enabling people whose lives have been disrupted by epilepsy to return comfortably to their regular activities. Their medicines are also tackling the effects of ageing on the brain. They are helping people with allergies to live more easily with their 21st century environment. Their scientists are continuing to seek new solutions to the challenges that are facing today’s healthcare providers. http://www.rxboomer.com/articles/Drug-Companies_17037.html Tue, 30 May 2006 06:21:36 CST A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.

Ther-Rx Corporation established in 1999, the Ther-Rx Corporation is a specialty pharmaceutical company dedicated to advancing medicine, making healthier life possible. Their goal is to make life a little easier for the women and men who use their products.

Ther-Rx Products use advanced drug-delivery technologies from their parent company, KV Pharmaceutical Company, they create medications that are easier to take, taste better, act faster, and last longer. By applying their highly advanced technologies in patient friendly ways, they're working together with KV to develop medicines that improve health care and well-being.

Currently, the Ther-Rx product line focuses on three specialty categories of Women's Health Care, Cardiovascular disease and Oral Hematinics. From advanced drug delivery comes enhanced branded prescription products.

PreCare Conceive is the first prescription prenatal vitamin supplement with essential nutrients for conception. PreCare Prenatal is the advanced and balanced prenatal formula for during and after pregnancy. PreCare Chewables is the advanced and balanced prenatal formula for during and after pregnancy.

Their commitment to promoting health and making life easier for women and men is based upon advanced technology. Ther-Rx incorporates innovative drug-delivery systems in their branded prescription products to produce medications that are easier to take, taste better, work faster, and last longer. Ther-Rx's product line focuses on three specialty categories: Women's Health Care, Cardiovascular disease and Anemia/oral iron replacement. http://www.rxboomer.com/articles/Drug-Companies_17036.html Tue, 30 May 2006 06:19:37 CST A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.
 
Israeli pharmacists and American physicians, led by the Levitt and Moros families, collaborate to establish Taro Pharmaceutical Industries Ltd. The company’s name taken from the Hebrew words for pharmaceutical industry reveals the dream of the founders. They believe that Taro can play a role in helping Israel, then just two years old, poor in natural resources, but rich in intellectual capital, to develop a world class pharmaceutical industry.

Taro entered the U.S. market in 1988, after establishing its Canadian subsidiary in 1984 and receiving approval of its first topical product in the United States. The U.S. has become Taro’s largest market, accounting for more than 80percent of their global sales. Their proprietary and generic U.S. products are both prescription and over the counter medications, sold in Taro label and private label store brand.

They include topical dermatological prescription pharmaceuticals creams, ointments, gels a category in which Taro is an acknowledged leader, as well as a growing line of oral dose drugs tablets and capsules used primarily in cardiovascular and neurological disorders. Taro U.S.A. maintains its own distribution facilities so that their U.S. customers, who include the largest drugstore chains and wholesalers, are assured of a continuous supply of Taro products.  Taro's first U.S. research operations were established in 2003. http://www.rxboomer.com/articles/Drug-Companies_17035.html Tue, 30 May 2006 06:17:53 CST TAP began in 1977 as a joint venture between two global pharmaceutical leaders, Abbott and Takeda Pharmaceutical Company Limited. Today, TAP is one of the nation's leading pharmaceutical companies and the marketer of Prevacid lansoprazole and Lupron Depot leuprolide acetate for depot suspension, both leaders in their classes.

TAP Pharmaceutical Products Inc. is a creative, diverse, and unique company led by a team dedicated to delivering high-quality pharmaceutical products for patients. TAP was created as a kind of virtual pharmaceutical company designed, without any internal discovery organization or manufacturing facilities. From the beginning, the company's corporate structure and business model were unique. TAP went outside for new compounds, and by doing so developed a flexible and versatile culture.

At first, TAP acquired early-stage drug compounds solely from one of its parent companies, Takeda. Today TAP works with both Abbott and Takeda and searches the world for in-licensing opportunities, focusing its efforts on rapid, high-quality drug development, and marketing and sales in North America.

TAP has built a culture from the bottom up, on a foundation of shared core values; TAP is a place where communication and collaboration are the keys to achieving goals. The people of TAP have created a spirit that is truly remarkable. In TAP's culture, everyone has a voice, and each voice is heard

Lupron Depot is indicated for the palliative treatment of advanced prostate cancer, for management of endometriosis, in combination with iron for the preoperative treatment of anemia caused by uterine fibroids, and for the treatment of children with central precocious puberty.

The indications for Prevacid include: the short-term treatment of heartburn and other symptoms of gastroesophageal reflux disease the GERD, the short-term up to eight weeks healing, symptom relief and maintenance of healed erosive esophagitis, a condition in which the lining of the esophagus has been damaged.

Over the years, TAP has also built one of the most highly trained and dedicated sales forces in the industry. TAP is proud of what they do and the way they do it. TAP's sales organization is the best in the business. The sales people function as a team, driven by their shared sense of purpose. They reach out to create partnerships with physicians; they collaborate with them to provide crucial health care information to patients, health care providers, managed care organizations, and hospitals. http://www.rxboomer.com/articles/Drug-Companies_17033.html Tue, 30 May 2006 06:15:47 CST Over two centuries ago in 1781, 32 year old Chobei Takeda  started a business selling traditional Japanese and Chinese medicines in Doshomachi, Osaka, the center of the medicine trade in Japan. His small shop bought medicines from wholesalers, then divided them into smaller batches and sold them to local medicine merchants and doctors. This was the beginning of the present day Takeda Chemical Industries, Ltd. 
 
Chobei Takeda IV led other medicine retailers in turning his attention to Western medicine. He formed a cooperative union for purchasing Western medicines in Yokohama and began transactions with foreign trading companies. Western medicines imported at the time included quinine, an anti-malaria drug and phenol, an anti-cholera drug.
 
Takeda began direct imports from England, the U.S., Germany, Spain and other countries around 1895 and in 1907 obtained exclusive sales rights in Japan for products from German company Bayer. Thus, the business that began as a shop selling old fashioned Japanese and Chinese remedies steadily increased its selection of Western medicines, before shifting its basic orientation to Western medicine.
 
Takeda Pharmaceuticals North America is a new kind of pharmaceutical company. They are dedicated to serving patients by providing innovative products that improve their lives with better healthcare.

Their unique culture sets them apart. They are committed to patients, their employees and the community. They have an innovative, entrepreneurial spirit combined with the rich history of their 220 year old parent company.

Headquartered in Lincolnshire, Illinois, a northern suburb of Chicago, the company is a wholly owned U.S. subsidiary of Takeda Pharmaceutical Company Limited, Japan’s largest pharmaceutical company. With more than five years of service in the U.S., they have grown rapidly and each step of that growth remains true to the company’s integrity, heritage and people.